Sarcoidosis: Epidemiology and clinical features

Ocular Immunology and Inflammation

Volumn 18, Issue 2, 2010, Pages 72-79

  Jones, Nicholas ^a   Mochizuki, Manabu ^b  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Diagnosis; Epidemiology; Ocular sarcoidosis; Sarcoidosis

Indexed keywords

ANTICONVULSIVE AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; INFLIXIMAB; METHOTREXATE; TRIAMCINOLONE ACETONIDE;

BLAU SYNDROME; CATARACT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; ERYTHEMA NODOSUM; ETHNIC DIFFERENCE; EYE SARCOIDOSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GLAUCOMA; HORMONE SUBSTITUTION; NEUROLOGICAL COMPLICATION; PREVALENCE; RADIOGRAPHY; RETINA MACULA CYSTOID EDEMA; REVIEW; SARCOIDOSIS; SEX RATIO; STAGING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; SARCOIDOSIS; SEX FACTORS; UVEITIS;

EID: 77950586095     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273941003710598     Document Type: Review

References (62)

1. Sharma OP. Sarcoidosis around the world. Clin Chest Med. 2008;29:357-363.
2. Boeck C. Multiple benign sarcoid of the skin. Norsk Mag Laegevid. 1899;14:1321-1345
3. Karakatsani A, Papakosta D, Rapti A, et al. Epidemiology of interstitial lung disease in Greece. Respir Med. 2009;103: 1122-1129
4. Demedts M, Wells AU, Anto JM, et al. Interstitial lung disease: an epidemiological overview. Eur Respir J Suppl. 2001;32:2s-16s
5. Bauer H, Lofgren S. International study of pulmonary sarcoidosis in mass radiography. Acta Med Scand. 1964;425(suppl):103-105
6. Siltzbach L, James D, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med. 1974;57:847-852
7. Izumi T. Population differences in clinical features and prognosis of sarcoidosis throughout the world: international survey report. Sarcoidosis. 1992;9(suppl 1):105-118
8. Selroos O. Differences in sarcoidosis around the world: what they tell us. In: Baughmann R, ed. Sarcoidosis: Lung Biology in Health and Disease, Vol 210. New York: Taylor & Francis; 2006:47-64
9. Pietinalho A, Hiraga Y, Hosoda Y, Lofroos AB, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan: a comparative epidemiological study. Sarcoidosis. 1995;12:61-67
10. Baughmann RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-1889 (Pubitemid 33152325)
11. Newman L, Rose C, Bresnitz R, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324-1330 (Pubitemid 39657197)
12. Hillerdal G, Nou E, Osterman K, et al. Sarcoidosis-epidemiology and prognosis: a 15-year European study. Am Rev Respir Dis. 1984;130:29-32 (Pubitemid 14092975)
13. Rybicki BA, Major M, Popovitch J. Racial differences in sarcoidosis incidence: a 5-year study in health maintenance organisation. Am J Epidemiol. 1997;145:234-241 (Pubitemid 27057175)
14. McGrath DS, Daniil Z, Foley P, et al. Epidemiology of familial sarcoidosis in the UK. Thorax. 2000;55:751-754 (Pubitemid 30660902)
15. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164:2085-2091
16. Tromp G, Kuivaniemi H, Raphael S, et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash and uveitis to chromosome 16. Am J Hum Genet. 1996;59:1097-1107 (Pubitemid 26346351)
17. Becker ML, Rose CD. Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep. 2007;7:427-433
18. Schurmann M, Valentonyte R, Hampe J, Muller-Quernheim J, Schwinger E, Schreiber S. CARD15 gene mutations in sarcoidosis. Eur Respir J. 2003;22:748-754 (Pubitemid 37369562)
19. James DG. Erythema nodosum. Br Med J. 1961;i:53-57
20. Wilsher ML. Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J. 1998;12:1197-1199 (Pubitemid 28545636)
21. Demirkok SS, Basaranoglu M, Coker E, Karayel T. Seasonality of the onset of symptoms, tuberculin test anergy and Kveim positive reaction in a large cohort of patients with sarcoidosis. Respirology. 2007;12:591-593 (Pubitemid 46961812)
22. Kucera GP, Rybicki BA, Kirkey KL, et al. Occupational risk factors for sarcoidosis in African-American siblings. Chest. 2003;123:1527-1535 (Pubitemid 36549772)
23. Rybicki BA, Amend KL, Malliarik MJ, Iannuzzi MC. Photocopier exposure and risk of sarcoidosis in African-American sibs. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21: 49-56
24. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med. 2007;28:22-35 (Pubitemid 46371213)
25. Mihailovic-Vucinic V, Jovanivic D. Pulmonary sarcoidosis. Clin Chest Med. 2008;29:459-473 (Pubitemid 351784485)
26. Lynch JP III, Ma YL, Koss MN, et al. Pulmonary sarcoidosis. Semin Respir Crit Care Med. 2007;28:53-74
27. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Resp Crit Care Med. 2001;164:1885-1889
28. Scadding JG. Prognosis of intrathoracic sarcoidosis in England; a review of 136 cases after five years' observation. Br Med J. 1961;2:1165-1172
29. Neville E, Walker A, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Quart J Med. 1983;52:525-533
30. Reich JM. Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy. Chest. 2002;121:32-39
31. Lynch JP III. Computed tomography scanning in sarcoidosis. Semin Respir Crit Care Med. 2003;24:393-418
32. Judson MA. Hepatic, splenic and gastrointestinal involvement with sarcoidosis. Semin Respir Crit Care Med. 2002;23:529-541
33. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest. 1993;103:253-258
34. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathological study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204-1211
35. Petursdottir D, Haraldsdottir SO, Gislason T, Gudbjornsson B. Clinical manifestation, prevalence and prognosis of sarcoid arthropathy. A nationwide study: the Icelandic Sarcoidosis Study. Sarcoidosis Vasc Diffuse Lung Dis. 2007;24:113-120
36. Torralba KD, Quismorio FP. Sarcoid arthritis: a review of clinical features, pathology and therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:95-103
37. Gullapalli D, Phillips LH. Neurologic manifestations of sarcoidosis. Neurol Clin. 2002;20:59-83
38. Allen RK, Sellars RE, Sandstrom PA. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:118-125
39. Lower EE, Weiss KL. Neurosarcoisosis. Clin Chest Med. 29;2008:475-492
40. Palacios E, Rigby PL, Smith DL. Cranial neuropathy in sarcoidosis. Ear Nose Throat J. 2003;82:251-252
41. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis: diagnosis and management. QJM. 1999;92:103-117
42. Scott TF, Yandora K, Valeri A, et al. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol. 2007;64:691-696
43. Baughmann RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2001;18: 70-74
44. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997; 336: 1224-1234.
45. ATS/ ERS/ WASOG Committee. Statement on sarcoidosis. Am J Respir Crit Care Med. 1999; 160: 736-755.
46. Yamamoto M, Sharma OP, Hosoda Y. Special report: the 1991 descriptive definition of sarcoidosis. Sarcoidosis. 1992; 9: 33-34.
47. Crick RP, Hoyle C, Smellie H. The eyes in sarcoidosis. Br J Ophthalmol. 1961; 45: 461-481.
48. Obenauf CD, Shaw HE, Syndor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978; 86: 648-655.
49. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986; 102: 297-301.
50. Ohara K, Okubo A, Sasaki H, Kamata K. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol. 1992; 36: 452-457.
51. Chumbley LC, Kearns TP. Retinopathy of sarcoidosis. Am J Ophthalmol. 1972; 73: 123-131.
52. Spalton DJ, Sanders MD. Fundus changes in histologically confirmed sarcoidosis. Br J Ophthalmol. 1981; 65: 348-358.
53. Cook BE Jr, Robertson DM. Confluent choroidal infiltrates with sarcoidosis. Retina. 2000; 20: 1-7.
54. Thorne JE, Brucker AJ. Choroidal white lesions as an early manifestation of sarcoidosis. Retina. 2000; 20: 8-15.
55. Wolfensberger TJ, Herbort CP. Indocyanine green angiographic features in ocular sarcoidosis. Ophthalmology. 1999; 106: 285-289.
56. Desai UR, Tawansy KA, Joondeph BC, Schiffman RM. Choroidal granulomas in systemic sarcoidosis. Retina. 2001; 21: 40-47.
57. Herbort CP, Mochizuki M, Rao NA, and Members of Scientific Committee of 1st IWOS. International criteria for the diagnosis of ocular sarcoidosis: results of the first international workshop on ocular sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009; 17: 160-169.
58. Kawaguchi T, Hanada A, Horie S, et al. Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol. 2007; 51: 121-126.
59. Takahashi T, Ohtani S, Miyata K, et al. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol. 2002; 46: 556-562.
60. Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis, 2nd ed. Intermediate Uveitis. St. Louis: Mosby; 1996:279-288.
61. Takase H, Shimizu K, Yamada Y, et al. Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the 1st international workshop on ocular sarcoidosis. Jpn J Ophthalmol. (in press)
62. Haimovici R, Foster CS. Ocular Infection & Immunity, Sarcoidosis. St. Louis: Mosby; 1996:754-776.